SKP2 and cancer: At first glance, this offers a molecular mechanism for the frequently observed Skp2 overexpression in many human cancers and links this phenomenon to the abnormal activation of the PI 3-K and Akt pathway, which is well-documented as being aberrantly activated in the majority of human cancers.